A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)

Clinical trial NCT00126451 · TERMINATED

Trial details

NCT number: NCT00126451
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Colorectal Cancer Non-small-cell Lung Carcinoma

Start date: 2004-12-01
Primary completion: 2005-10-11
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.